Loading...

Analysts Mixed on Wacker Chemie as Price Targets Fall Amid Slightly Lower Growth Forecasts

Published
22 Dec 24
Updated
02 Apr 26
Views
151
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
45.7%
7D
3.0%

Author's Valuation

€73.526.7% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 02 Apr 26

Fair value Increased 5.65%

WCH: Future Returns Will Depend On Delivering Modest 2026 Guidance

Analysts have lifted the implied fair value estimate for Wacker Chemie from about €69.57 to €73.50. This reflects recent upgrades and a higher Street price target of €61, which collectively point to adjusted assumptions on revenue growth, margins and future P/E multiples.

Analyst Commentary

Recent Street research on Wacker Chemie points to a mixed but more engaged view, with several upgrades alongside a slightly higher price target of €61. Here is how bullish and bearish analysts are framing the story around valuation, growth and execution.

Bullish Takeaways

  • Bullish analysts see the recent upgrades as a sign that earlier assumptions on revenue growth and margins were too conservative, which supports a higher implied fair value estimate.
  • The move in the Street price target to €61 is viewed by optimists as a step toward closing the gap between current market pricing and their higher fair value estimates near €73.50.
  • Positive rating changes are interpreted as increased confidence in Wacker Chemie’s ability to execute on its operational plans, which feeds into higher assumed future P/E multiples.
  • Supportive research commentary signals that some on the Street are willing to underwrite a more constructive long term outlook for earnings quality and capital allocation.

Bearish Takeaways

  • Bearish analysts, including those maintaining more cautious ratings, still see enough execution or cycle risk to justify a price target at €61, below the lifted fair value estimate.
  • The retention of an Underweight stance by at least one major firm suggests ongoing concerns about risk and reward compared with other stocks, even after the price target adjustment.
  • Cautious voices may view the higher fair value estimate as reliant on assumptions for revenue growth and margins that could prove demanding if conditions are less supportive.
  • The gap between Street targets and the higher implied fair value keeps the focus on whether Wacker Chemie can deliver consistent operational performance to support richer P/E multiples.

What’s in the News

  • Wacker Chemie issued earnings guidance for the first quarter of 2026, with management indicating expected sales of about €1.35b (company guidance).
  • For the full year 2026, the company is guiding to modest growth, with group sales expected to be up by a low single-digit percentage (company guidance).

Valuation Changes

  • Fair Value: the implied fair value estimate has risen slightly from about €69.57 to €73.50.
  • Discount Rate: the updated discount rate has moved marginally higher from 6.21% to about 6.31%.
  • Revenue Growth: the assumed revenue growth rate has increased from roughly 1.32% to about 2.84%.
  • Net Profit Margin: the projected profit margin has eased from about 3.69% to roughly 3.12%.
  • Future P/E: the assumed future P/E multiple has risen from about 19.5x to roughly 23.7x.
5 viewsusers have viewed this narrative update

Key Takeaways

  • Strategic investments and focus on high-value specialty products position Wacker for long-term growth in renewables and advanced electronics markets.
  • Emphasis on sustainability, cost optimization, and regulatory tailwinds is expected to drive improved margins and resilient earnings.
  • Softer demand, rising competition, currency pressures, and regulatory uncertainty are undermining profitability and growth while high fixed costs threaten margins if utilization does not improve.

Catalysts

About Wacker Chemie
    Provides chemical products worldwide.
What are the underlying business or industry changes driving this perspective?
  • Completion of major strategic investments and new polysilicon and specialty chemicals capacities positions Wacker to benefit long term from rising demand in renewable energy (solar and battery storage) and advanced electronics, likely supporting higher revenue growth and operational leverage once demand recovers.
  • Accelerated shift in product mix toward high-value, specialty silicones and sustainable solutions (including biosolutions), combined with focused innovation and digitization initiatives, is expected to improve net margins over the next business cycle as Wacker moves away from more commoditized, lower-margin products.
  • Proactive cost reduction and cash optimization measures, including reduced CapEx, working capital improvements, and plant productivity initiatives, should enhance free cash flow and earnings resilience, particularly as volumes recover or economic headwinds abate.
  • Broader global momentum toward decarbonization and customer focus on sustainable supply chains (highlighted by positive response to Wacker's new carbon footprint tool) will likely drive structurally higher demand for Wacker's eco-friendly and energy-efficient materials, underpinning long-term revenue growth.
  • Regulatory and policy developments in key markets (such as potential Section 232 in the U.S., possible reductions in Chinese polysilicon overcapacity, or supportive EU/German industrial policy) could improve industry pricing power and market access, acting as catalysts for earnings upside if implemented.
Wacker Chemie Earnings and Revenue Growth

Wacker Chemie Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Wacker Chemie's revenue will grow by 2.8% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -15.0% today to 3.1% in 3 years time.
  • Analysts expect earnings to reach €186.4 million (and earnings per share of €3.42) by about April 2029, up from -€821.1 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €279.5 million in earnings, and the most bearish expecting €115.6 million.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 24.0x on those 2029 earnings, up from -5.0x today. This future PE is lower than the current PE for the GB Chemicals industry at 28.8x.
  • Analysts expect the number of shares outstanding to grow by 0.61% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.31%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Persistent weak demand and heightened competition across Wacker's core markets-particularly in silicones, polymers, and solar-grade polysilicon-are driving sequential and year-over-year declines in revenue and EBITDA, raising risk of prolonged revenue stagnation if these secular headwinds do not abate.
  • Significant currency headwinds, especially from an unfavorable euro-U.S. dollar exchange rate and limited long-term hedging, are compressing both reported revenues and EBITDA, with further strengthening of the euro potentially eroding international earnings.
  • Structural overcapacity and intense price competition in the polysilicon market-exacerbated by Chinese producers-continue to weigh on pricing power and capacity utilization, risking future impairments, lower profitability, and reduced earnings in Wacker's key segments.
  • Recent major capital investments have increased depreciation and fixed costs, resulting in underutilized assets and lower gross profit margins as top-line growth stalls; if asset utilization does not improve, net margins and free cash flow are likely to stay pressured.
  • The company faces mounting regulatory and geopolitical uncertainty-including trade policy volatility, energy pricing reforms, and unresolved outcomes of U.S. trade investigations like Section 232-which could unpredictably impact long-term access to key markets, input costs, and revenue streams.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €73.5 for Wacker Chemie based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €96.0, and the most bearish reporting a price target of just €50.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €6.0 billion, earnings will come to €186.4 million, and it would be trading on a PE ratio of 24.0x, assuming you use a discount rate of 6.3%.
  • Given the current share price of €83.05, the analyst price target of €73.5 is 13.0% lower. Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Wacker Chemie?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives